Immediate vs. Delayed Stenting in Primary PCI

Original Title: Comparison of Immediate With Delayed Stenting Using the Minimalist Immediate Mechanical Intervention Approach in Acute ST-Segment–Elevation Myocardial Infarction. The MIMI Study. Reference: Loic Belle et al. Circ Cardiovasc Interv. 2016 Mar;9(3).

 

Delayed stenting after normal epicardial flow restoration is meant to lower the chance of distal embolization and to improve reperfusion in the context of primary PCI.

This study was designed to compare the minimalist technique of delayed stenting (a las 24-48 hs) vs. immediate stenting in patients undergoing ST elevation MI, receiving primary PCI.

It included 140 patients undergoing ≤12 hr. evolution STEMI randomized to immediate stenting (n=73) vs delayed stenting (n=67) after TIMI flow III restoration by thromboaspiration.

Patients in the delayed stenting group had a second stenting procedure at mean 36 hrs. after randomization (range 29-46 hrs.).

Primary end point was micro vascular obstruction by MRI at 5 days after the first procedure.

A minor tendency to less micro vascular obstruction in the immediate stent group was observed, compared to the delayed stent group (1.88% vs 3.96%; p=0.051); this difference became significant after adjusting for area at risk (p=0.049).

Mean infarction size and ejection fraction resulted similar between the groups.

There were no differences in cardiovascular events after 6 months.

Conclusion
The result of this study does not support the delayed stenting strategy in patients undergoing primary PCI and even suggests it could be detrimental.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....